← Back to Dashboard

Galidesivir

RNA-dependent RNA polymerase (RdRp) inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

C1=C(C2=C(N1)C(=NC=N2)N)C3C(C(C(N3)CO)O)O
AMFDITJFBUXZQN-KUBHLMPHSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus13

Yellow fever virus
YFV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:25155605 NCT03891420
Zaire ebolavirus
EBOV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT02319772
Marburg marburgvirus
MARV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT03800173
Zika virus
ZIKV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:27838352
Dengue virus
DENV-2
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28473729 PMID:24590073
Hepacivirus C
HCV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PubChem CID:69211190
Japanese encephalitis virus
JEV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28473729
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24590073
Marburg marburgvirus
RAVV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24590073
Rift Valley fever phlebovirus
RVFV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:29864447
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24590073
Tick-borne encephalitis virus
TBEV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28336346
West Nile virus
WNV
Target: Viral RNA pol
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28336346